A pathological examination proved the lesion to be carcinoma in situ of the conjunctiva with invasion into cornea 在10个月追踪过程中，肿瘤自行消退，无复发现象。
Twenty - seven patients had the removal of struts 10 - 12 months postoperatively with better cosmetic appearance 27例保留金属支杠于术后10 - 12个月拔除者，无复发，外观更满意。
Two cases had recurrence 2 years and 2 . 5 years after operation , but both were well controlled after the second operation 6例中3例术后无复发，迄今存活期分别为6年、 8年及14年。
Conclusions our five - gene signature is closely associated with relapse - free and overall survival among patients with nsclc 结论：我们的五个基因标记与非小细胞肺癌患者的无复发及总生存率密切相关。
Results : followed up from 4 to 6 years postoperatively , only a patient recurred and received another operation one year and a half later , the recurrence rate was 2 . 78 % 结果：术后随访4 ~ 6年， 1例于手术后1年半复发而再次手术，其他患者无复发，复发率为2 . 78 % 。
We report a 64 - year - old man previously diagnosed with limited stage small cell lung cancer that presented with painless hematuria and arf after a 2 - year relapse - free period 我们报告一位六十四岁先前诊断为局限阶段小细胞肺癌的男性病人，经过两年无复发时期后，呈现出无痛性血尿和急性肾衰竭。
Nine of 22 patients accepted more than one time of tae according to the curative effect and progress of the disease , but reduction of tumor size or necrosis could be achieved in all these patients 22例患者均无复发出血及急性肝功能衰竭， 9例患者经栓塞术后，再根据病情行多次介入治疗，肿瘤均有不同程度的缩小和坏死。
They found that high numbers of foxp3 - positie lymphocytes in breast biopsies predicted an increased risk of relapse in patients with ductal carcinoma in situ ( dcis ) , plus shorter relapse - free and oerall surial in patients with inasie tumors 他们发现，乳腺活组织检查中大量foxp3阳性的淋巴细胞可预测原位管癌患者具有高复发危险,对于浸润癌患者其无复发时间及总生存率缩短。
It has been suggested that patients with hepatocellular carcinoma ( hcc ) undergoing living donor liver transplantation ( ldlt ) have worse recurrence - free survival compared to deceased donor liver transplantation ( clt ) , leading to the hypothesis that short waitlist time or fast - tracking may include more aggressive tumors that would have been selected out by traditionally longer waitlist time 因有已经提议认为肝细胞癌的患者，接受活体供体肝移植的相对于尸体供体肝移植而言，有更坏的存活期无复发率（即更快的移植后复发率） ，导致了认为可能包括更有侵袭性的肿瘤的患者应该在传统的长时间等待名单上被挑选出来，以短暂等待时间或者快速示踪（的方式尽快接受肝移植的）假说。
